Accessibility Menu
 
TerrAscend logo

TerrAscend

(OTC) TRSSF

Current PriceN/A
Market CapN/A
Since IPO (2017)-47%
5 Year-94%
1 Year+33%
1 Month-4%

TerrAscend Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$260.56M

Net Income (TTM)

$81.33M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TerrAscend

Industry

Pharmaceuticals

Employees

1,038

CEO

Ziad Ghanem, PharmD

Headquarters

Mississauga, ON L5B 4A7, CA

TRSSF Financials

Key Financial Metrics (TTM)

Gross Margin

51%

Operating Margin

15%

Net Income Margin

-32%

Return on Equity

-73%

Return on Capital

8%

Return on Assets

-15%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$136.32M

Operating Income

$42.02M

EBITDA

$46.44M

Operating Cash Flow

$33.93M

Capital Expenditure

$0.00

Free Cash Flow

$33.93M

Cash & ST Invst.

$37.41M

Total Debt

$47.32M

TerrAscend Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$59.45M

-20.0%

Gross Profit

$32.36M

+20.7%

Gross Margin

54.43%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

972

N/A

Net Income

$4.90M

+115.4%

EBITDA

$1.03M

-109.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$9.90M

+95.5%

Accounts Receivable

$16.90M

-10.5%

Inventory

$34.05M

-30.2%

Long Term Debt

$35.45M

-84.9%

Short Term Debt

$11.87M

+6.6%

Return on Assets

-15.21%

N/A

Return on Invested Capital

8.46%

N/A

Free Cash Flow

$5.87M

+122.0%

Operating Cash Flow

$8.33M

+125.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CCHWFColumbia Care Inc.
$0.94-21.71%
AIHLFAdcock Ingram Holdings Limited
$3.50+0.00%
IVEVFInventiva S.A.
$5.50+0.00%
CKDXFOpthea Limited
$0.44+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
INTCIntel
$48.03+0.09%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NKENike
$44.63-0.16%

Questions About TRSSF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.